- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有243家主力机构披露2026-06-30报告期持股数据，持仓量总计1.89亿股，占流通A股45.42%
- 波段诊断：
-
技术面诊股
诊断结果：5.4技术面打败了60%的股票
技术面评分前10的股票
近期的平均成本为35.64元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为35.64元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"35.64","date":1789028292,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2026.09.11","stock":"-1.24","trade":"-2.77","ind":"-1.08"},{"date":"2026.09.10","stock":"-1.38","trade":"-2.42","ind":"-0.77"},{"date":"2026.09.09","stock":"-1.26","trade":"-0.75","ind":"0.15"},{"date":"2026.09.08","stock":"1.14","trade":"3.08","ind":"-0.52"},{"date":"2026.09.07","stock":"0.05","trade":"0.78","ind":"1.91"},{"date":"2026.09.04","stock":"-1.65","trade":"-0.66","ind":"-0.79"},{"date":"2026.09.03","stock":"-0.85","trade":"-0.62","ind":"0.10"},{"date":"2026.09.02","stock":"-2.35","trade":"-0.97","ind":"-1.88"},{"date":"2026.09.01","stock":"-0.44","trade":"0.33","ind":"-1.02"},{"date":"2026.08.31","stock":"-1.62","trade":"-1.36","ind":"0.44"},{"date":"2026.08.28","stock":"-3.09","trade":"-2.63","ind":"-0.68"},{"date":"2026.08.27","stock":"0.10","trade":"0.58","ind":"1.50"},{"date":"2026.08.26","stock":"0.15","trade":"-1.23","ind":"0.69"},{"date":"2026.08.25","stock":"-2.91","trade":"2.61","ind":"-0.35"},{"date":"2026.08.24","stock":"-0.71","trade":"-3.21","ind":"-2.13"},{"date":"2026.08.21","stock":"-3.61","trade":"-3.87","ind":"0.87"},{"date":"2026.08.20","stock":"16.44","trade":"5.90","ind":"0.59"},{"date":"2026.08.19","stock":"-3.86","trade":"-4.93","ind":"-5.01"},{"date":"2026.08.18","stock":"-1.68","trade":"-1.82","ind":"-0.56"},{"date":"2026.08.17","stock":"-2.12","trade":"0.26","ind":"2.44"},{"date":"2026.08.14","stock":"-3.10","trade":"-0.33","ind":"0.45"}]
华大基因,深证成指,医疗服务指数
压力支撑
该股压力位为35.69元，支撑位为35.06元。
[{"text":"\u538b\u529b\u4f4d","value":"35.69","date":1789056000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"35.06","date":1789056000,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.5资金面打败了17%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：09月11日 20:30
| 机构今日流向(万元) | -1334.03 | 机构5日流向(万元) | -2677.42 |
| 机构10日流向(万元) | -5657.62 | 机构20日流向(万元) | -24369.92 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少1114.58万股，其中基金净减仓26家，主力净增仓4家，暂未发现中长期投资价值。
截止2026-06-30，共243家主力机构（基金238家，一般法人5家），持仓量总计18895.94万股，占流通A股45.42%
其中，基金持仓与2025-12-31相比：
增仓：60家 ，增持 330.52万股
减仓：86家 ，减持 561.13万股
新出现在主力名单中：77家 ，持有338.12万股
从主力名单中消失：73家 ，原持有1306.63万股
其中，基金持仓与2025-12-31相比：
增仓：60家 ，增持 330.52万股
减仓：86家 ，减持 561.13万股
新出现在主力名单中：77家 ，持有338.12万股
从主力名单中消失：73家 ，原持有1306.63万股
消息面诊股
诊断结果：5.5消息面打败了34%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 华大基因：9月10日获融资买入884.17万元
2026-09-11 - 万亿元主动健康赛道加速变革，华大集团首席执行官尹烨
2026-09-10 - 衰老数字化、营养精准化、护肤个体化，华大新品发布会
2026-09-10 - 华大基因：9月9日获融资买入1703.35万元
2026-09-10 - 智感生命度量，重构主动健康 | 华大基因开启生命数
2026-09-09 - 华大基因：9月8日获融资买入2279.91万元
2026-09-09 - 广州市白云区人民医院与华大基因战略合作签约仪式在深
2026-09-08 - 华大基因：9月7日获融资买入1462.97万元
2026-09-08 - 华大基因：9月4日获融资买入2156.75万元
2026-09-07 - 行业周报|医疗服务指数跌-3.25%, 跑输上证指
2026-09-04
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-22 |
| 一般消息 | 重大事项 | 关联交易 | 2026-08-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-08-19 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-06-12 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-05-29 |
| 一般消息 | 重大事项 | 关联交易 | 2026-05-29 |
| 一般消息 | 高管变动 | 因即将达到法定退休年龄 | 2026-05-07 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-25 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-25 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-04-21 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-04-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-03 |
| 利好 | 业绩预告 | 预计减亏 | 2026-01-28 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-01-28 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-28 |
| 一般消息 | 高管变动 | 工作安排 | 2026-01-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-05 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-03 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-12 |
| 一般消息 | 重大事项 | 关联交易 | 2025-10-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-30 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-09-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-15 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：2.4行业面打败了25%的股票
医疗服务行业最新资金流向
近10日来该行业走势总体向下，跑输大盘。
行业走势
近10日来该行业走势总体向下，跑输大盘。
[{"date":"2026.09.11","price":"-1.08","value":"-2.77"},{"date":"2026.09.10","price":"-0.77","value":"-2.42"},{"date":"2026.09.09","price":"0.15","value":"-0.75"},{"date":"2026.09.08","price":"-0.52","value":"3.08"},{"date":"2026.09.07","price":"1.91","value":"0.78"},{"date":"2026.09.04","price":"-0.79","value":"-0.66"},{"date":"2026.09.03","price":"0.10","value":"-0.62"},{"date":"2026.09.02","price":"-1.88","value":"-0.97"},{"date":"2026.09.01","price":"-1.02","value":"0.33"},{"date":"2026.08.31","price":"0.44","value":"-1.36"},{"date":"2026.08.28","price":"-0.68","value":"-2.63"},{"date":"2026.08.27","price":"1.50","value":"0.58"},{"date":"2026.08.26","price":"0.69","value":"-1.23"},{"date":"2026.08.25","price":"-0.35","value":"2.61"},{"date":"2026.08.24","price":"-2.13","value":"-3.21"},{"date":"2026.08.21","price":"0.87","value":"-3.87"},{"date":"2026.08.20","price":"0.59","value":"5.90"},{"date":"2026.08.19","price":"-5.01","value":"-4.93"},{"date":"2026.08.18","price":"-0.56","value":"-1.82"},{"date":"2026.08.17","price":"2.44","value":"0.26"},{"date":"2026.08.14","price":"0.45","value":"-0.33"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | ST中珠 | 4.87% | 9.22% | 5.3分 |
| 2 | 阳光诺和 | 4.53% | -2.96% | 5.5分 |
| 3 | 皓宸医疗 | 1.59% | -2.67% | 5.7分 |
| 4 | 国际医学 | 1.16% | 7.41% | 6.0分 |
| 5 | 光正眼科 | 1.01% | -1.48% | 5.8分 |
| 6 | 澳洋健康 | 0.44% | 8.31% | 5.2分 |
| 8 | 大东方 | -0.50% | 0.76% | 4.8分 |
| 10 | 百诚医药 | -3.96% | 10.61% | 5.3分 |
| 12 | 药明康德 | -4.72% | -1.68% | 6.5分 |
| 14 | 南华生物 | -5.88% | 2.72% | 5.7分 |
| 16 | - | -6.11% | -7.93% | 分 |
| 18 | 华康洁净 | -6.55% | -8.74% | 5.2分 |
| 20 | 何氏眼科 | -8.22% | -3.41% | 4.7分 |
| 22 | 美年健康 | -10.14% | -1.95% | 5.1分 |
| 24 | 华大基因 | -11.74% | -2.69% | 4.5分 |
| 26 | 皓元医药 | -12.79% | -1.74% | 5.8分 |
| 28 | 益诺思 | -13.13% | 4.09% | 6.0分 |
| 30 | 金域医学 | -13.81% | -2.96% | 4.9分 |
| 32 | 三博脑科 | -15.67% | -6.38% | 4.2分 |
| 34 | 九洲药业 | -16.82% | -3.21% | 4.8分 |
| 36 | 美迪西 | -17.86% | -4.18% | 5.9分 |
| 38 | 迪安诊断 | -18.16% | -4.44% | 5.3分 |
| 40 | 百奥赛图 | -18.85% | 0.43% | 7.2分 |
| 42 | 金凯生科 | -20.27% | -8.21% | 3.8分 |
| 44 | 百花医药 | -21.00% | -8.63% | 4.2分 |
| 46 | 兰卫医学 | -21.34% | -5.36% | 4.1分 |
| 48 | 药石科技 | -24.79% | -3.77% | 4.5分 |
| 50 | 海特生物 | -25.62% | -8.48% | 4.0分 |
| 52 | 泓博医药 | -26.72% | -4.49% | 4.3分 |
| 54 | 普蕊斯 | -32.70% | -8.41% | 3.6分 |
| 56 | 万邦医药 | -38.22% | -4.78% | 3.9分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 37/102 ， 20/102。
[{"date":"2026-06-30","value":"0.56","vol":"2.39"},{"date":"2026-03-31","value":"-0.11","vol":"0.96"},{"date":"2025-12-31","value":"-7.00","vol":"2.21"},{"date":"2025-09-30","value":"-0.23","vol":"3.24"},{"date":"2025-06-30","value":"0.06","vol":"2.24"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.56 | -0.11 | -7.00 | -0.23 | 0.06 |
| 行业(%) | 2.39 | 0.96 | 2.21 | 3.24 | 2.24 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"41.52","vol":"34.37"},{"date":"2026-03-31","value":"39.71","vol":"34.16"},{"date":"2025-12-31","value":"37.59","vol":"34.36"},{"date":"2025-09-30","value":"42.97","vol":"36.06"},{"date":"2025-06-30","value":"44.65","vol":"36.21"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
41.52 | 39.71 | 37.59 | 42.97 | 44.65 |
| 行业(%) | 34.37 | 34.16 | 34.36 | 36.06 | 36.21 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 23/102 ， 6/102。
[{"date":"2026-06-30","value":"9.59","vol":"16.81"},{"date":"2026-03-31","value":"20.35","vol":"16.75"},{"date":"2025-12-31","value":"-4.18","vol":"8.22"},{"date":"2025-09-30","value":"-5.39","vol":"3.06"},{"date":"2025-06-30","value":"-12.82","vol":"2.87"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
9.59 | 20.35 | -4.18 | -5.39 | -12.82 |
| 行业(%) | 16.81 | 16.75 | 8.22 | 3.06 | 2.87 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"718.24","vol":"134.87"},{"date":"2026-03-31","value":"81.93","vol":"79.49"},{"date":"2025-12-31","value":"31.69","vol":"23.26"},{"date":"2025-09-30","value":"82.78","vol":"20.05"},{"date":"2025-06-30","value":"-68.25","vol":"-63.31"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
718.24 | 81.93 | 31.69 | 82.78 | -68.25 |
| 行业(%) | 134.87 | 79.49 | 23.26 | 20.05 | -63.31 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 40/102 ， 31/102。
[{"date":"2026-06-30","value":"0.16","vol":"0.22"},{"date":"2026-03-31","value":"0.07","vol":"0.10"},{"date":"2025-12-31","value":"0.31","vol":"0.44"},{"date":"2025-09-30","value":"0.22","vol":"0.32"},{"date":"2025-06-30","value":"0.13","vol":"0.21"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.16 | 0.07 | 0.31 | 0.22 | 0.13 |
| 行业(次) | 0.22 | 0.10 | 0.44 | 0.32 | 0.21 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"2.14","vol":"7.15"},{"date":"2026-03-31","value":"1.03","vol":"3.44"},{"date":"2025-12-31","value":"4.28","vol":"15.84"},{"date":"2025-09-30","value":"2.72","vol":"10.95"},{"date":"2025-06-30","value":"1.55","vol":"7.15"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.14 | 1.03 | 4.28 | 2.72 | 1.55 |
| 行业(次) | 7.15 | 3.44 | 15.84 | 10.95 | 7.15 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 52/102 ， 38/102。
[{"date":"2026-06-30","value":"-9.74","vol":"15.88"},{"date":"2026-03-31","value":"-22.43","vol":"0.86"},{"date":"2025-12-31","value":"36.20","vol":"20.95"},{"date":"2025-09-30","value":"-2.19","vol":"16.52"},{"date":"2025-06-30","value":"-1.75","vol":"16.38"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -9.74 | -22.43 | 36.20 | -2.19 | -1.75 |
| 行业 | 15.88 | 0.86 | 20.95 | 16.52 | 16.38 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.96","vol":"0.94"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.89","vol":"0.89"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.97","vol":"0.91"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.96 | - | 0.89 | - | 0.97 |
| 行业 | 0.94 | 0.00 | 0.89 | 0.01 | 0.91 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 23/102 ， 38/102。
[{"date":"2026-06-30","value":"2.81","vol":"3.00"},{"date":"2026-03-31","value":"2.60","vol":"3.37"},{"date":"2025-12-31","value":"2.42","vol":"3.64"},{"date":"2025-09-30","value":"2.81","vol":"3.67"},{"date":"2025-06-30","value":"2.81","vol":"3.57"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.81 | 2.60 | 2.42 | 2.81 | 2.81 |
| 行业 | 3.00 | 3.37 | 3.64 | 3.67 | 3.57 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"2.50","vol":"2.40"},{"date":"2026-03-31","value":"2.31","vol":"2.78"},{"date":"2025-12-31","value":"2.18","vol":"3.00"},{"date":"2025-09-30","value":"2.49","vol":"2.94"},{"date":"2025-06-30","value":"2.49","vol":"2.87"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.50 | 2.31 | 2.18 | 2.49 | 2.49 |
| 行业 | 2.40 | 2.78 | 3.00 | 2.94 | 2.87 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 34/102 ， 36/102。
[{"date":"2026-06-30","value":"23.11","vol":"33.06"},{"date":"2026-03-31","value":"24.73","vol":"32.97"},{"date":"2025-12-31","value":"26.74","vol":"32.98"},{"date":"2025-09-30","value":"23.82","vol":"32.60"},{"date":"2025-06-30","value":"24.81","vol":"33.58"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
23.11 | 24.73 | 26.74 | 23.82 | 24.81 |
| 行业(%) | 33.06 | 32.97 | 32.98 | 32.60 | 33.58 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.30","vol":"0.90"},{"date":"2026-03-31","value":"0.33","vol":"0.97"},{"date":"2025-12-31","value":"0.37","vol":"0.97"},{"date":"2025-09-30","value":"0.32","vol":"0.92"},{"date":"2025-06-30","value":"0.33","vol":"0.96"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.30 | 0.33 | 0.37 | 0.32 | 0.33 |
| 行业(%) | 0.90 | 0.97 | 0.97 | 0.92 | 0.96 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"8.03","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.93","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-9.03","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-6.17","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"1.13","blueLineValue":"0.27","type":"YC"}]